GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway
Cell Metabolism · 2023-08 · 35 (8) · 1341-1355.e3
DOI: 10.1016/j.cmet.2023.06.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2023-08. Verfasst von Samuel N Breit und 5 weiteren Autor:innen. Beteiligte Einrichtung: St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney and University of New South Wales, Sydney, NSW 2010, Australia. Elect…. Hauptthemen laut MEDLINE: Adiposity, Leptin. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
GDF15 regulates its anorexic effects through the hindbrain area postrema (AP) and nucleus of the solitary tract (NTS) neurons where its receptor, glial-derived neurotrophic factor receptor alpha-like (GFRAL), is expressed. The actions of GDF15 may interact with other appetite regulators elevated in obesity, such as leptin. Here, we report that in mice with high-fat-diet-induced obesity (HFD), the combined infusion of GDF15 and leptin causes significantly greater weight and adiposity loss than either treatment alone, indicating potentiation between GDF15 and leptin. Furthermore, obese, leptin-deficient ob/ob mice are less responsive to GDF15, as are normal mice treated with a competitive leptin antagonist. GDF15 and leptin induce more hindbrain neuronal activation in HFD mice than either treatment alone does. We report extensive connections between GFRAL- and LepR-expressing neurons and find LepR knockdown in the NTS to reduce the GDF15-mediated activation of AP neurons. Overall, these findings suggest that leptin signaling pathways in the hindbrain increase GDF15's metabolic actions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney and University of New South Wales, Sydney, NSW 2010, Australia. Electronic address: s.breit@unsw.edu.au.
- St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney and University of New South Wales, Sydney, NSW 2010, Australia.
- Westmead Institute for Medical Research and Department of Immunopathology, Institute for Clinical Pathology and Medical Research-New South Wales Health Pathology Westmead Hospital and University of Sydney, Sydney, NSW 2…
- St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney and University of New South Wales, Sydney, NSW 2010, Australia. Electronic address: v.tsai@amr.org.au.
Zitieren
APA
Breit, S. N., Manandhar, R., Zhang, H. P., Lee-Ng, M., Brown, D. A., & Tsai, V. W. (2023). GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway. Cell Metabolism, 35(8), 1341-1355.e3. https://doi.org/10.1016/j.cmet.2023.06.009
Vancouver
Breit SN, Manandhar R, Zhang HP, Lee-Ng M, Brown DA, Tsai VW. GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway. Cell Metabolism. 2023;35(8):1341-1355.e3. doi:10.1016/j.cmet.2023.06.009
BibTeX
@article{Breit2023,
author = {Breit, Samuel N and Manandhar, Rakesh and Zhang, Hong-Ping and Lee-Ng, Michelle and Brown, David A and Tsai, Vicky Wang-Wei},
title = {GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway},
journal = {Cell Metabolism},
year = {2023},
volume = {35},
number = {8},
pages = {1341--1355.e3},
doi = {10.1016/j.cmet.2023.06.009}
}
EUVIMED